STEFANY HASTINGS: Open Payments
NPI 1891179057 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 78 payments from 24 companies in 2025. Trend: 2023 $1,254 · 2024 $1,151 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $194 |
| PFIZER INC. | 13 | $165 |
| Novo Nordisk Inc | 12 | $163 |
| ABBVIE INC. | 10 | $162 |
| Lilly USA, LLC | 6 | $104 |
| Lundbeck LLC | 3 | $79 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Ardelyx, Inc. | 2 | $56 |
| Organon LLC | 2 | $55 |
| Dexcom, Inc. | 2 | $50 |
Products named: Ozempic, FARXIGA, REXULTI, MOUNJARO, AIRSUPRA, NURTEC ODT, VRAYLAR, UBRELVY.
Industry payments across MO — which companies pay providers there.
